Olmes, Gregor Leonhard
Zimmermann, Julia Sarah Maria
Stotz, Lisa
Takacs, Ferenc Zoltan
Hamza, Amr
Radosa, Marc Philipp
Findeklee, Sebastian
Solomayer, Erich-Franz
Radosa, Julia Caroline
Funding for this research was provided by:
Universitätsklinikum des Saarlandes (HOMFOR2016 T201000789)
Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes
Article History
Received: 2 February 2021
Accepted: 15 June 2021
First Online: 5 August 2021
Declarations
:
: The authors declare the following conflicts of interests. JC Radosa has received travel grants from Medac GmbH (Wedel, Germany), Gedeon. Richter (Budapest, Hungary), Celgene (Summit, NJ, USA), Daiichi Sankyo (Tokyo, Japan), and Pfizer (New York City, NY, USA) and has been an honorary speaker for Pfizer. L.S. has received travel grants from Medac GmbH (Wedel, Germany) and Celgene (Summit, USA) outside the scope of this work. E.-F.S. is receiving grants from the University of Saarland, Storz, and Erbe; personal fees and other compensation from Roche (Basel, Switzerland), Pfizer (New York City, NY, USA), Celgene (Summit USA), Amgen (Thousand Oaks, CA, USA), and Astra Zeneca (Cambridge, UK); and other fees from Esai (Tokyo, Japan), Ethicon (Somerville, NJ, USA), Johnson & Johnson (New Brunswick, NJ, USA), Novartis (Basel, Switzerland), Tesaro (Waltham, MA, USA), Teva (Petach Tikwa, Israel), Medac GmbH (Wedel, Germany), MSD (Kenilworth, NJ, USA), Vifor (Sankt Gallen, Switzerland), Gedeon Richter (Budapest, Hungary), Takeda (Tokyo, Japan), and AGE (Buchholz, Germany). L Stotz has received travel grants from Medac GmbH and Celgene outside the submitted work in the past. ZF Takacs has been honary speaker for Samsung and Dr. Kade GmbH. GL Olmes, JSM Zimmermann, A Hamza, MP Radosa, S Findeklee do not have conflicts of interests.
: Waiver.
: Waiver.
: Waiver.